Evolus (EOLS) Receivables (2019 - 2026)
Evolus (EOLS) posted Receivables of $52.2 million for Q1 2026, down 4.53% on a QoQ basis from $54.7 million in Q4 2025, and up 10.04% year-over-year from $47.5 million in Q1 2025.
Evolus (EOLS) Receivables (2019 - 2026) Analysis & Trends
Evolus' Receivables history runs 8 years deep, the most recent figure standing at $52.2 million for Q1 2026.
- Quarterly Receivables rose 10.04% year-over-year to $52.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.2 million (up 10.04% YoY) and the FY2025 annual result came in at $54.7 million, up 14.71% from the prior year.
- Receivables was $52.2 million for Q1 2026 at Evolus, down from $54.7 million in the prior quarter.
- Across five years, Receivables topped out at $54.7 million in Q4 2025 and bottomed at $16.8 million in Q1 2022.
- A 5-year average of $36.3 million and a median of $34.2 million in 2024 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables jumped 296.82% — and 2026, when it advanced 10.04%.
- Evolus' Receivables stood at $22.4 million in 2022, then jumped by 36.0% to $30.5 million in 2023, then surged by 56.19% to $47.7 million in 2024, then grew by 14.71% to $54.7 million in 2025, then decreased by 4.53% to $52.2 million in 2026.
- Business Quant data shows EOLS's Receivables at $52.2 million in Q1 2026, $54.7 million in Q4 2025, and $50.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 52.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.22 Mn |
| Dec 31, 2025 | 54.70 Mn |
| Sep 30, 2025 | 50.44 Mn |
| Jun 30, 2025 | 47.71 Mn |
| Mar 31, 2025 | 47.45 Mn |
| Dec 31, 2024 | 47.68 Mn |
| Sep 30, 2024 | 44.64 Mn |
| Jun 30, 2024 | 43.15 Mn |
| Mar 31, 2024 | 34.24 Mn |
| Dec 31, 2023 | 30.53 Mn |
| Sep 30, 2023 | 30.46 Mn |
| Jun 30, 2023 | 29.00 Mn |
| Mar 31, 2023 | 23.46 Mn |
| Dec 31, 2022 | 22.45 Mn |
| Sep 30, 2022 | 20.92 Mn |
| Jun 30, 2022 | 21.03 Mn |
| Mar 31, 2022 | 16.80 Mn |
| Dec 31, 2021 | 5.66 Mn |
| Sep 30, 2021 | 13.29 Mn |
| Jun 30, 2021 | 11.86 Mn |